PMV Pharmaceuticals, Inc.
PMVP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001699382
No open-market purchases or sales by PMV Pharmaceuticals, Inc. insiders were filed in the last 90 days; 64 institutions reported holding it in 13F filings for Q2 2026, worth $45.9M in total; no superinvestor holds it.
Q1 2022 vs. Q4 2021
How the institutions holding PMV Pharmaceuticals, Inc. changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Of which not filed for Q1 2022 | Q1 2022 | Change |
|---|---|---|---|---|
| Holders | 105 | 2 | 99 | −4 |
| Shares | 47.5M | 97.8K | 55.2M | +7.88M (+16.6%) |
| Value | $1.10B | $2.26M | $1.15B | +$55.7M (+5.1%) |
2 institutions that held it in Q4 2021 haven't filed for Q1 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (15)
Institutions that held PMV Pharmaceuticals, Inc. at the end of Q1 2022 but not at the end of Q4 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Cowen and Company, LLC | 1,261,529 | $26.3M | 2.65% |
| Healthcare of Ontario Pension Plan Trust Fund | 781,600 | $16.3M | 0.06% |
| Norges Bank | 238,200 | $4.96M | 0.00% |
| Acuta Capital Partners, LLC | 135,500 | $2.82M | 1.34% |
| Integral Health Asset Management, LLC | 50,000 | $1.04M | 0.27% |
| Caption Management, LLC | 23,318 | $485.0K | 0.03% |
| Blueshift Asset Management, LLC | 13,635 | $284.0K | 0.03% |
| Barclays PLC | 8,709 | $182.0K | 0.00% |
| Amalgamated Bank | 4,271 | $89.0K | 0.00% |
| Amalgamated Financial Corp. | 4,271 | $89.0K | 0.00% |
| Nisa Investment Advisors, LLC | 1,200 | $25.0K | 0.00% |
| Assetmark, Inc | 261 | $5.00K | 0.00% |
| Lindbrook Capital, LLC | 264 | $5.00K | 0.00% |
| Signaturefd, LLC | 143 | $3.00K | 0.00% |
| Prospera Financial Services Inc | 136 | $3.00K | 0.00% |
Sold out (19)
Institutions that held PMV Pharmaceuticals, Inc. at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Sphera Funds Management Ltd. | 190,525 | $4.40M |
| Perceptive Advisors LLC | 125,000 | $2.89M |
| SG Americas Securities, LLC | 91,464 | $2.11M |
| Millennium Management LLC | 68,845 | $1.59M |
| Cubist Systematic Strategies, LLC | 66,743 | $1.54M |
| HighVista Strategies LLC | 39,777 | $919.0K |
| Susquehanna Fundamental Investments, LLC | 33,568 | $775.0K |
| Voloridge Investment Management, LLC | 23,971 | $554.0K |
| Qube Research & Technologies Ltd | 18,168 | $420.0K |
| Jump Financial, LLC | 14,593 | $337.0K |
| Trexquant Investment LP | 13,264 | $306.0K |
| Credit Suisse AG | 8,942 | $207.0K |
| Hershey Trust Co | 3,841 | $89.0K |
| Point72 Hong Kong Ltd | 3,785 | $87.0K |
| Quantbot Technologies LP | 1,700 | $39.0K |
| TCI Wealth Advisors, Inc. | 182 | $4.00K |
| Parallel Advisors, LLC | 23 | $1.00K |
| Simplex Trading, LLC | 24 | $0 |
| Covestor Ltd | 17 | $0 |
Not filed for Q1 2022 yet (2)
Institutions that held PMV Pharmaceuticals, Inc. at the end of Q4 2021 and haven't filed a 13F for Q1 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Asymmetry Capital Management, L.P. | 97,680 | $2.26M |
| NEXT Financial Group, Inc | 170 | $4.00K |